4.5 Article

Prediction of complications of type 2 Diabetes: A Machine learning approach

Journal

DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 190, Issue -, Pages -

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2022.110013

Keywords

Diabetes complications; Machine learning; Artificial intelligence; Predictive models; Clinical inertia; Quality of care

Funding

  1. METEDA s.r.l. (Rome, Italy) [153, 30/9/2019]
  2. Universit`a Politecnica delle Marche (Ancona, Italy)
  3. Astra-Zeneca
  4. NovoNordisk
  5. Shionogi
  6. Theras
  7. Astra Zeneca
  8. Eli Lilly
  9. Boehringer
  10. Associazione Medici Diabetologi (AMD)

Ask authors/readers for more resources

This study constructed predictive models of diabetes complications using big data machine learning and demonstrated their accuracy and sensitivity through validation.
Aim: To construct predictive models of diabetes complications (DCs) by big data machine learning, based on electronic medical records.Methods: Six groups of DCs were considered: eye complications, cardiovascular, cerebrovascular, and peripheral vascular disease, nephropathy, diabetic neuropathy. A supervised, tree-based learning approach (XGBoost) was used to predict the onset of each complication within 5 years (task 1). Furthermore, a separate prediction for early (within 2 years) and late (3-5 years) onset of complication (task 2) was performed. A dataset of 147.664 patients seen during 15 years by 23 centers was used. External validation was performed in five additional centers. Models were evaluated by considering accuracy, sensitivity, specificity, and area under the ROC curve (AUC).Results: For all DCs considered, the predictive models in task 1 showed an accuracy > 70 %, and AUC largely exceeded 0.80, reaching 0.97 for nephropathy. For task 2, all predictive models showed an accuracy > 70 % and an AUC > 0.85. Sensitivity in predicting the early occurrence of the complication ranged between 83.2 % (peripheral vascular disease) and 88.5 % (nephropathy).Conclusions: Machine learning approach offers the opportunity to identify patients at greater risk of complica-tions. This can help overcoming clinical inertia and improving the quality of diabetes care.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available